• 医学部公共卫生学院
    School of Public Health,Medical College of Soochow University
    江苏省老年病预防与转化医学重点实验室
    Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases
  • 网站首页Home
  • 实验室介绍About lab
  • 实验室机构Agency of lab
    • 组织机构
    • 学术委员会
  • 研究方向Research area
  • 队伍建设Rsearchers
    • 学术带头人
    • 学术队伍
  • 研究成果Achievements
    • 科研项目
    • 科研论文
    • 科研专利
    • 科研获奖
  • 学术交流Academic exchange
    • 开放课题
    • 学术讲座
  • 仪器设置Instrument
    • 仪器设置
  • 规章制度Rules and regulations
  • 联系我们Contact Us
    • 联系方式
    • 留言反馈
    学术交流
    • 开放课题
    • 学术讲座

    Ocular Toxicity and Advances in its Detection



    时间:5月18号上午9:00-10:00
    地点:独墅湖校区医学楼杏林会议室(401号楼1412)
    题目:Ocular Toxicity and Advances in its Detection
    演讲人:Dr. Edward Chow
    Scientific Director (Research Investigator) at Allergan.

     

    Dr. Edward Chow 简介

    Dr. Chow has been a toxicologist for 30 years and is currently Scientific Director (Research Investigator) at Allergan, the tenth largest pharmaceutical company in the world.

    Dr. Chow received his bachelor degree in biochemistry from the University of California in Berkeley, and his doctoral degree in pharmacology and toxicology from the University of California in Davis.

    After post-doctoral work at the University of California in Riverside, he became a study director at Ciba-Geigy (later became Novartis) and directed general toxicology, neurotoxicology, and carcinogenicity studies on pesticides and animal health products. A few years later, Dr. Chow moved on to a program management role and oversaw the generation of toxicology data to support development of novel fungicidal molecules, some of them had become blockbusters, and chaired a regulatory and legal team that successfully defended products from being listed as teratogens or carcinogens in California (under a law called “Proposition 65”).

    After joining Allergan in 2000, he has written and supervised numerous IND's on systemic, dermal, and ophthalmic drug candidates, and has served as a subject matter expert on due diligence teams with in-licensing opportunities. He has direct experience on both small and large molecule drug candidates to treat stomach ulcer, nocturia, urinary bladder pain, neuropathic pain, rosacea, glaucoma, or age-related macular degeneration. He has served as the President of the “American Association of Chinese in Toxicology”, a 250-member “Special Interest Group” within the Society of Toxicology, and as the President of the “Ocular Toxicology Special Section”, a 100-member “Specialty Section” within the Society of Toxicology. Dr. Chow is a reviewer for the journal “Cutaneous and Ocular Toxicology” and has made presentations at the conferences of the Society of Toxicology as well as the Chinese Society of Toxicology.

    欢迎师生积极参加!

     

    苏州大学医学部公共卫生学院

    2016年5月10日

    医学部公共卫生学院
    School of Public Health,Medical College
    版权所有 © 苏州大学医学部公共卫生学院
    地址:苏州工业园区仁爱路199号   邮编:215123   电话:0512-65883323